AzTrials
AzTrials

Acute Kidney InjuryNCT06202326

Role of Renal Artery Doppler in Critically Ill Children With Acute Kidney Injury

An observational study of Acute Kidney Injury, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To detect frequency of acute kidney injury in critically ill children in Assuit university hospital. To detect associated AKI risk factors, severity and outcomes . To assess the value of use of renal Doppler ultrasound in AKI. Read more about this study

Who is it for?
Ages 1 month to 18 years
Conditions the study is for
Acute Kidney Injury
What is being tested?
renal artery doppler
Type of treatment
Medical device
How many people
45 participants
Where
No sites listed yet
Study dates
Apr 2024to Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 18 years
  • All sexes
  • Child, Adult

Study population: critically ill children in emergency unit and PICU.

Who may be able to join

  • Critically ill children aged more than 1 month up to 18 years who were admitted in Assuit University Children Hospital.
  • Critically ill and admitted in emergency unit more than 24hrs
  • -

Who cannot join

  • 1- Neonates ( age less than 1months) and adults (more than 18years). 2- Patient with chronic kidney disease on dialysis. 3- Patient with hospital stay duration less 24 hrs. 4- Patient with congenital kidney disease

Trial locations and contacts

No sites are listed yet.

Nardeen Elway, assistant lecturer contact

01212810204

nardeenchristdd@gmail.com

dr.Zeinab Mohyee El Deen, Professor of Pediatrics contact

01149913112

About this study

Official title: Role of Renal Artery Doppler In Critically Ill Children With Acute Kidney Injury

To detect frequency of acute kidney injury in critically ill children in Assuit university hospital.

To detect associated AKI risk factors, severity and outcomes . To assess the value of use of renal Doppler ultrasound in AKI.

Read the detailed description

Critically ill child is defined as a child whose baseline state of health has significantly changed and whose life is at risk as a result of an illness or injury and they in big need for intensive care whether medicallyor surgically.

Acute kidney injury (AKI) is characterized by a sudden and generally revertible renal function impairment , involving inability to maintain the homeostasis, and may or not be accompanied by reduced diuresis. (1) Acute kidney injury (AKI) is highly prevalent among hospitalized children, with incidence rates ranging from 5% in non-critically ill children to 50% in those admitted to pediatric emergency units (2). This disease is strongly associated with worse outcomes, including increased mortality, increased use of mechanical ventilation, and prolonged hospital stay (3). AKI prevalence due to sepsis ranges from 9% to 40%, involves poor prognosis, and is associated with a 70% mortality rate (4). Among critically ill renal impaired patients, about 6% the septic shock, is one of the main causes of AKI. may need renal replacement therapy (RRT), with a mortality rate increased by 50 to 80%, particularly associated with sepsis, septic shock, and multiple organ and systems dysfunction MODS (5).

During the childhood, the main AKI causes are sepsis, nephrotoxic drugs, and renal ischemia in critically ill patients (1) .These patients, particularly those staying in intensive care units , are exposed to a number of conditions which may result in renal impairment ,thus significantly increasing the morbidity and mortality rate. (6).

Among the main causes that should be mentioned : hypovolemia leading to hypoperfusion and consequent hypoxia; inflammatory and thrombotic events caused by bacteremia ; systemic inflammation from trauma, major surgeries, extracorporeal circulation ;use of vasodilator drugs such as phosphodiesterase inhibitors, sedatives, epidural blockade; vasopressors; and use of nephrotoxic drugs as aminoglycosides, amphotericin B, radiological contrasts, and drugs interfering with the renal hemodynamics such as angiotensin converting enzyme inhibitors and angiotensin II receptor blockers (3).

In 2004, a consensus definition for AKI was proposed by the Acute Dialysis Quality Initiative (ADQI) : the RIFLE criteria (risk, injury ,failure, loss, end-stage renal disease) (7) .The adult-derived RIFLE definition was modified, and then applied and validated in pediatric patients and renamed as the pediatric RIFLE criteria. pRIFLE stratifies AKI from mild (RIFLE R, risk) to severe (RIFLE F, failure) based on changes in SCR or estimated creatinine clearance and urine output .Similar to adult studies AKI defined by these criteria was an independent risk factor for both increased hospital length of stay and mortality.

Currently, the most widely used criteria for diagnosing and staging AKI is the Kidney Disease Improving Global Outcomes (KDIGO) criteria, which is based on acute changes in serum creatinine (sCr) and/or reduced urine output (UO) (8). These criteria have limitations, especially in children. Significant sCr elevations can be delayed 24 to 48 hours after a renal insult and are commonly seen only after at least 50% of renal function loss. In addition, children may have very low sCr levels at baseline, which can make it difficult to identify relative increases when values remain within normal ranges. To overcome these limitatio, point-of-care ultrasonography has been proposed as a reliable and safe method to both diagnose and predict the occurrence of AKI in ICU patients (8).

The AKI diagnosis methods include: clinical evaluation of the urine output and laboratory tests as urine analysis, blood urea nitrogen, and creatinine, however with low sensitivity and specificity.(9). Biomarkers for early AKI detection are currently under investigation, among them neutrophil gelatinase associated lipocalin (NGAL), cystatin C, interleukin 18, and kidney injury molecule-1(KIM1). Although these markers have good sensitivity and specificity, they are not routinely used due to their low availability and high costs(10). So there is a need for a method valid ,early, simple for early detection of AKI.

Renal arterial Doppler-based parameters, such as renal resistive index (RRI) or renal pulsatility index (RPI), are rapid, noninvasive, and repeatable variables that may be promising for early AKI detection. Because it reflects resistance to blood flow, lower RRI values are associated with better renal perfusion, while increased values are associated with progression to ATN (11). However, there is a lack of evidence supporting the use of this technique in PICU. Therefore, this study aims to assess the accuracy of renal arterial Doppler ultrasound (RDU) to predict AKI in mechanically ventilated children.

The complement system, which is a part of the innate immune system, is involved in mechanism of AKI , and thus could present a unifying therapeutic target in the pathophysiology of AKI development in children who are critically ill. The complement cascade is made up of three activation pathways: classic, alternative, and lectin. These three pathways feed into the "terminal complement cascade." These pathways generate protein fragments that can be quantified to determine the level of complement activation in each pathway in a given disease: C4a (classic and lectin pathways), Factors Ba and Bb (alternative pathway), C3a (all three pathways), and sC5b-9 (terminal pathway). The kidney is particularly susceptible to complement activation because complement proteins are concentrated in the kidney via glomerular filtration and activation is promoted via the kidney's acidic environment and ammonia synthesis (12). Complement factors have been shown to be instrumental in the pathogenesis of AKI in basic science models of sepsis and ischemia reperfusion injury (13,14). All three pathways have been implicated in the pathogenesis of a wide variety of kidney diseases (11,15,16).

Being tested
renal artery doppler
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • renal artery dopplerDevice

    doppler ultrasound follow up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. early detection of AKI in critically ill children

    renal artery doppler can help in detection of AKI in early stage by calculate renal resistive index and renal pulsaltility index

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2024
  2. Study startApr 2024 (estimated)
  3. Primary completionApr 2025 (estimated)
  4. Study completionJun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06202326
Sponsor's protocol ID
AKI in critically ill children
Status last verified
Jan 2024
First submitted
1 Jan 2024
Last updated
11 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nardeen Elway, assistant lecturer (01212810204, nardeenchristdd@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

early detection of AKI in critically ill children (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06202326 | AzTrials